238 related articles for article (PubMed ID: 22036215)
1. Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis.
Feng X; Reder NP; Yanamandala M; Hill A; Franek BS; Niewold TB; Reder AT; Javed A
J Neurol Sci; 2012 Feb; 313(1-2):48-53. PubMed ID: 22036215
[TBL] [Abstract][Full Text] [Related]
2. Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
Kovacs KT; Kalluri SR; Boza-Serrano A; Deierborg T; Csepany T; Simo M; Rokusz L; Miseta A; Alcaraz N; Czirjak L; Berki T; Molnar T; Hemmer B; Illes Z
Mult Scler; 2016 Aug; 22(9):1192-201. PubMed ID: 26514978
[TBL] [Abstract][Full Text] [Related]
3. Spinal cord syndromes in patients with systemic lupus erythematosus: differentiating lupus myelitis, neuromyelitis optica, and multiple sclerosis.
Williams JN; Speyer CB; Kreps DJ; Kimbrough DJ; Costenbader K; Bhattacharyya S
Lupus; 2019 Dec; 28(14):1656-1662. PubMed ID: 31679449
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha association with neuromyelitis optica.
Asgari N; Voss A; Steenstrup T; Kyvik KO; Stenager E; Lillevang ST
Clin Dev Immunol; 2013; 2013():713519. PubMed ID: 24348680
[TBL] [Abstract][Full Text] [Related]
5. Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica.
Tortorella C; Ruggieri M; Di Monte E; Ceci E; Iaffaldano P; Direnzo V; Mastrapasqua M; Frigeri A; Amato MP; Hakiki B; Ghezzi A; Lugaresi A; De Luca G; Patti F; D'Amico E; Sola P; Simone AM; Svelto M; Livrea P; Trojano M
J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1355-9. PubMed ID: 21622936
[TBL] [Abstract][Full Text] [Related]
6. Serum analysis by 1H nuclear magnetic resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.
Moussallieh FM; Elbayed K; Chanson JB; Rudolf G; Piotto M; De Seze J; Namer IJ
Mult Scler; 2014 Apr; 20(5):558-65. PubMed ID: 24080986
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
Wang H; Wang K; Wang C; Zhong X; Qiu W; Hu X
Mult Scler; 2013 Jun; 19(7):926-31. PubMed ID: 23012252
[TBL] [Abstract][Full Text] [Related]
8. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
Oke V; Gunnarsson I; Dorschner J; Eketjäll S; Zickert A; Niewold TB; Svenungsson E
Arthritis Res Ther; 2019 Apr; 21(1):107. PubMed ID: 31036046
[TBL] [Abstract][Full Text] [Related]
9. Poor responses to interferon-beta treatment in patients with neuromyelitis optica and multiple sclerosis with long spinal cord lesions.
Wang KC; Lin KH; Lee TC; Lee CL; Chen SY; Chen SJ; Chin LT; Tsai CP
PLoS One; 2014; 9(6):e98192. PubMed ID: 24887452
[TBL] [Abstract][Full Text] [Related]
10. Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission.
Wang S; Yang T; Wan J; Zhang Y; Fan Y
Brain Behav; 2017 Apr; 7(4):e00648. PubMed ID: 28413701
[TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
[TBL] [Abstract][Full Text] [Related]
12. Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis.
Correale J; Fiol M
Mult Scler; 2011 May; 17(5):521-31. PubMed ID: 21159721
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of remitting neuromyelitis optica spectrum disorders from multiple sclerosis by integrating parameters from serum proteins and lymphocyte subsets.
Ip PP; Chung CY; Chang CC; Lee YF; Wang HM; Lian IB; Fann CS; Yang CC; Liao F
J Neuroimmunol; 2018 May; 318():45-52. PubMed ID: 29455925
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against interferon-beta in neuromyelitis optica patients.
Asgari N; Kyvik KO; Steenstrup T; Stenager E; Lillevang ST
J Neurol Sci; 2014 Apr; 339(1-2):52-6. PubMed ID: 24477087
[TBL] [Abstract][Full Text] [Related]
15. Serum concentration of CD40L is elevated in inflammatory demyelinating diseases.
Zhong X; Wang H; Ye Z; Qiu W; Lu Z; Li R; Shu Y; Chang Y; Hu X
J Neuroimmunol; 2016 Oct; 299():66-69. PubMed ID: 27725124
[TBL] [Abstract][Full Text] [Related]
16. Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis.
Shu Y; Li R; Qiu W; Chang Y; Sun X; Fang L; Chen C; Yang Y; Lu Z; Hu X; Kermode AG
Mult Scler Relat Disord; 2017 Nov; 18():65-70. PubMed ID: 29107207
[TBL] [Abstract][Full Text] [Related]
17. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S
J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387
[TBL] [Abstract][Full Text] [Related]
18. Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin.
Lambers WM; de Leeuw K; Doornbos-van der Meer B; Diercks GFH; Bootsma H; Westra J
Arthritis Res Ther; 2019 Dec; 21(1):260. PubMed ID: 31791398
[TBL] [Abstract][Full Text] [Related]
19. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
Lennon VA; Wingerchuk DM; Kryzer TJ; Pittock SJ; Lucchinetti CF; Fujihara K; Nakashima I; Weinshenker BG
Lancet; 2004 Dec 11-17; 364(9451):2106-12. PubMed ID: 15589308
[TBL] [Abstract][Full Text] [Related]
20. Activation of humoral immunity and eosinophils in neuromyelitis optica.
Correale J; Fiol M
Neurology; 2004 Dec; 63(12):2363-70. PubMed ID: 15623701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
